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Abstract 14-3-3 proteins play a role in many cellular functions 
as molecular chaperone and adapter proteins: they bind to and 
modulate several proteins involved in cell proliferation and 
differentiation, and also function ATP-dependently in targeting 
of precursors to mitochondria. We show here that 14-3-3 purified 
from a human lymphoblastoma and also its recombinant T 
isoform exhibited intrinsic nucleoside diphosphate (NDP) kinase-
like activity. 14-3-3 proteins preferentially catalyzed the transfer 
of the y-phosphate group from ATP, dATP or dGTP to all 
nucleoside diphosphates and this transfer involved acid-labile 
phosphoenzyme intermediates. They also simultaneously cata-
lyzed the reverse reaction of ATP hydrolysis. These properties of 
14-3-3 are similar to those of N D P kinase, but not to those of 
adenylate kinase. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
14-3-3 proteins, first discovered as abundant , acidic proteins 
in the brain, are ubiquitously distributed (reviewed in [1,2]). 
At least five isoforms and two of their phosphorylated forms 
have been identified in mammals [3]. Although the exact func-
tion of 14-3-3 proteins is not known, numerous biological 
activities have been attributed to them. They were first impli-
cated as activators of neuronal tyrosine and t ryptophan hy-
droxylases [4] and of Ca 2 + -dependent exocytosis from chro-
maffin cells [5], and as regulators of protein kinase C [6,7]. 
More recently, with development of the yeast two-hybrid sys-
tem, 14-3-3 proteins were shown to bind to a number of 
important signaling proteins with phosphorylated serine, 
such as Raf-1, Bcr-Abl, Bcr, polyoma middle T antigen, PI-
3 kinase (reviewed in [8,9]) and glycoprotein Ib-IX [10] and 
cell-cycle control proteins such as Cdc25 phosphatases [11]. 
Fur thermore 14-3-3 proteins have also been identified as cy-
tosolic chaperone-like proteins with ATPase activity as prin-
cipal stimulators of mitochondrial import [12-14], 
Though the known functions of 14-3-3 are very varied, 
most of them share the feature of modulating activity by 
mediating protein-protein interaction [14—16]. Hsp70 family 
proteins, molecular chaperones, that exhibit weak ATPase 
activity, bind to A T P and A D P , and the resulting change in 
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nucleotide exchange regulates substrate protein binding and 
its dissociation [17-21]. In view of the mechanisms for molec-
ular chaperone-protein interaction, 14-3-3 proteins, which act 
as both chaperones and adapter molecules [14-16], may also 
require A T P / A D P exchange for their function in a cycle of 
substrate binding and release. 
In this paper, we report intrinsic A T P / A D P exchange activ-
ity as a novel activity of 14-3-3. The characteristics of the 
enzyme activity are similar to those of nucleoside diphosphate 
(NDP) kinases, but not to those of adenylate kinase. 
2. Materials and methods 
2.1. Materials 
14-3-3 was purified from human lymphoblastoma T-cell line (Molt-
4, Clone 8 cells) as described [6]. BSA, NDP kinase from bovine liver, 
various ribo- and deoxyribo-nucleoside tri-, di-, and monophosphates, 
AMP-PNP, and ATPyS were purchased from Sigma Chemical 
Co. (St. Louis, MO). [8-14C]ADP, [2-14C]CDP, [8-14C]ATP, and 
[Y-32P]ATP were obtained from Du Pont-New England Nuclear. A 
monoclonal antibody against human nm23-Hl protein (human 
NDP kinase-A) was from Novocastra Laboratories, UK. 
2.2. Expression and purification of recombinant 14-3-3 fusion proteins 
Recombinant human 14-3-3 i fusion protein with a hexahistidine 
tag at the amino terminus was created by generating BamHl and 
£coRI restriction sites at the 5' and 3' end, respectively, of human 
14-3-3 cDNAs by the polymerase chain reaction. The cDNA products 
were subcloned into the vector pET-21a+ (Novagen), transformed 
into E. coli BL21(DE3) and purified by TALON metal affinity resin 
(Clontech Laboratories, Inc.) chromatography according to the man-
ufacturer's instructions. Homogeneity was confirmed by SDS-PAGE 
followed by Coomassie Brilliant Blue staining. 
2.3. Assay of ATP hydrolysis and ATP synthesis 
The ATP hydrolysis and ATP synthesis activities of 14-3-3 were 
analyzed by measuring the conversion of [14C]ATP to [14C]ADP, 
and that of [14C]ADP to [14C]ATP, respectively, as described 
[22,23]. The reactions were carried out at 37°C for 6 h in Buffer A 
(100 mM HEPES-KOH, pH 8, 5 mM ATP, 0.5 mM ADP, 6 mM 
MgCl2) with 0-3.3 ug of 14-3-3, and 0.05 uCi of [8-14C]ATP or 0.02 
uCi of [8-14C]ADP in assays of ATP hydrolysis and ATP synthesis 
activity, respectively, in a total volume of 20 ul. After incubation, 
samples of the reaction mixtures were promptly spotted onto poly-
ethylene-imino-cellulose TLC plates (Macherey-Nagel). ADP and 
ATP were separated by ascending chromatography in 1 M formic 
acid containing 0.7 M LiCl and the radioactivities of the resolved 
spots were quantitated with a Bio Imaging Analyzer BAS 1500 
(Fuji Photo Film Co., Japan). 
2.4. Nucleotide specificity of 14-3-3 as phosphate acceptor 
The nucleotide specificity of 14-3-3 proteins was examined by in-
cubation at 37°C for 6 h in Buffer B (100 mM HEPES-KOH, pH 8, 
1 uCi of [y-32P]ATP, 6 mM MgCl2) with 33 pmol (calculated as a 
monomer with a mean molecular mass of 30 kDa) of 14-3-3 and 
0.5 mM concentrations of various ribo- or deoxyribo-nucleoside di-
phosphates as phosphate acceptors in 20 ul of reaction mixture [24]. 
After incubation, the nucleotides were resolved by polyethylene-imi-
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no-cellulose TLC in 0.75 M KH2PO4, pH 3.5, and quantified with an 
imaging analyzer. 
2.5. Detection of autophosphorylated 14-3-3 intermediates 
Autophosphorylation and CDP-dependent dephosphorylation of 
14-3-3 proteins were analyzed using 1-3 ug of 14-3-3 proteins or its 
recombinant T isoform, 10 uCi of [y-32P]ATP (6000 Ci/mmol), 100 uM 
ATP and 6 mM MgCl2 in 100 mM HEPES-KOH, pH 8, in the 
presence and absence of 5 mM CDP, respectively, in a total volume 
of 20 |il. After incubation at 37°C for 6 h, both reactions were 
quenched by addition of 6 mM EDTA and cooling on ice, and half 
of each sample was then treated with SDS sample buffer without 
boiling and subjected to 15% SDS-PAGE. After electrophoresis, the 
gel was dried without acid fixation and analyzed with an imaging 
analyzer. The other halves of the samples were analyzed by TLC 
and then imaging analysis. The acid and base stability of phosphoryl-
ated 14-3-3 proteins was analyzed as described [25]. 
3. Results 
3.1. Characterization of 14-3-3 proteins purified from a human 
lymphoblastoma and its recombinant 14-3-3 T isoform 
14-3-3 proteins purified from a human lymphoblastoma and 
the recombinant 14-3-3 x isoform showed two bands with 
molecular masses of 28 and 32 kDa and a band of 28 kDa, 
respectively, without visible contaminating proteins on SDS-
PAGE (Fig. 1). 14-3-3 proteins from a human lymphoblasto-
ma were a mixture of at least the 6 isoforms, such as the x, £, 
r|, ß and y isoforms of 28 kDa and the e isoform of 32 kDa, 
which were identified by Western immunoblotting analysis 
with isoform specific antibodies (data not shown). We used 
the recombinant 14-3-3 x isoform for experiments because of 
its abundant expression in human T-cells [26,27]. To confirm 
its identity and purity, we digested the recombinant x isoform 
with lysyl endopeptidase, separated the peptide fragments by 
HPLC and sequenced their amino acids in a Perkin Elmer 
Applied Biosystems 492 protein sequencer. All peptides de-
rived from the purified recombinant protein had identical se-
quences to the corresponding sequences deduced from the 
nucleotide sequence of the human x isoform (data not shown). 
3.2. Intrinsic nucleoside diphosphate kinase-like activity of 
14-3-3 
The ATPase activity of 14-3-3 proteins was first implicated 
Fig. 1. SDS-PAGE and Western blot analyses of 14-3-3 from a hu-
man lymphoblastoma and the recombinant 14-3-3 x isoform. 14-3-3 
(2 ug) purified from a human lymphoblastoma (lane 1) and the re-
combinant 14-3-3 x isoform (1 ug) purified (lane 2) were analyzed 
by SDS-PAGE (15-25% gradient) under denaturing and reducing 
conditions followed by Coomassie Brilliant Blue staining. Western 
blot immunoanalyses of 14-3-3 proteins from the human lympho-
blastoma (lane 4), its recombinant 14-3-3 x isoform (lane 5) and 
NDP kinase as a positive control (lane 3) (0.1 ug of each) probed 
with a monoclonal antibody against human nm23-Hl protein (hu-
man NDP kinase-A) followed by detection with ECL Western blot-
ting reagents. 
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Fig. 2. Characterization of the activities of 14-3-3 proteins for ATP 
hydrolysis and ATP synthesis. A: Time course of ATP hydrolysis of 
14-3-3 proteins purified from a human lymphoblastoma. ATP hy-
drolysis was analyzed under the conditions given in Section 2 using 
30 pmoles of 14-3-3, 5 mM ATP, 0.05 uCi of [8-14C]ATP and 6 mM 
MgCl2 in the presence (■) or absence (D) of 0.5 mM ADP. The ac-
tivity in the presence of 0.5 mM AMP instead of ADP (o) was also 
analyzed. After 6 h reaction at pH 8, samples were analyzed by 
TLC and ADP formation was calculated with an imaging analyzer. 
As a negative control, BSA (30 pmol) ( A ) was analyzed instead of 
14-3-3. B: Dose-response curves of the effect of 14-3-3 (0-100 pmol) 
on activity for ATP synthesis with 5 mM ATP, 0.02 uCi of 
[8-14C]ADP and 6 mM MgCl2 in the presence (•) or absence (■) of 
0.5 mM ADP. The ATP synthesis activity was also analyzed with 
0.5 mM AMP instead of ADP ( A ) . The ATP synthesis activity of 
the recombinant x isoform (0-50 pmol) (D) was also analyzed. 
Dose-response curves of 14-3-3 (0-100 pmol) on the activities of 
ATP hydrolysis (o) and the recombinant x isoform ( A ) (0-50 
pmoles) were analyzed with 5 mM ATP, 0.5 mM ADP, 0.05 uCi of 
[8-14C]ATP and 6 mM MgCl2 in the reaction mixture. 
in the function of ATP-dependent conformational modulators 
which stimulate the import of precursor proteins into mito-
chondria [12-14]. We found that the ATPase activity of 14-3-3 
proteins was stimulated up to 6.7-fold by 0.5 mM ADP, but 
not by AMP (Fig. 2A), although ADP is a product inhibitor 
of common ATPase. The enzyme activities with and without 
0.5 mM ADP were linear with time for 6 h. Furthermore, the 
activity was linear at concentrations of up to about 20-30 
pmol, and was then curvilinear (Fig. 2B). The rates of ATP 
hydrolysis with 30 pmol of 14-3-3 proteins were determined in 
reaction mixture in the presence of increasing concentrations 
of ATP and 0.5 mM ADP and the Km for ATP was estimated 
to be 1.41 mM (data not shown). Slight inhibition was ob-
served with concentrations of above 2 mM ADP (data not 
shown). 
Then we analyzed the reverse reaction of the enzyme, the 
activity for ATP synthesis. The enzyme exhibited activity for 
ATP synthesis in the presence of 5 mM ATP, 0.5 mM ADP 
and 6 mM MgC^, but not in the presence of 0.5 mM AMP 
instead of 0.5 mM ADP. ATP synthesis activity of this en-
zyme was not detected in the presence of ADP without nu-
cleoside triphosphate, such as ATP, in the reaction mixture 
(Fig. 2B). These results suggest that the activity was similar to 
that of NDP kinase, but not adenylate kinase. The activity for 
ATP synthesis was linear with up to about 20-30 pmol of 
enzyme and the rate was similar to that for ATP hydrolysis. 
The Km value of the activity for ATP synthesis from ADP was 
estimated to be 0.2 mM (data not shown). Since both Km 
values are slightly lower than the concentrations of ATP 
( ~ 5 mM) and ADP (~0.5 mM) in the cytosol, changes in 
substrate availability would be expected to affect the in vivo 
enzyme reaction significantly. The purified recombinant 14-3-3 
x isoform also exhibited both ATP hydrolysis and ATP syn-
thesis activities, as shown in Fig. 2B, although the activities 
for ATP hydrolysis and ATP synthesis were 32% and 48%, 
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Fig. 3. Comparison of various ribo- and deoxyribo-nucleoside tri-
phosphates used as phosphate donors for the conversion of ADP to 
ATP by 14-3-3 and NDP kinase. The ATP synthesis activities of 
14-3-3 proteins (30 pmoles) (A) and NDP kinase (10 pmoles) (B) 
were analyzed after incubation for 6 h and 30 min, respectively, 
under the conditions given in Section 2 using 0.5 mM ADP, 0.02 
uCi of [8-14C]ADP, 6 mM MgCb and 5 mM concentrations of vari-
ous ribo-, deoxyribo-nucleoside triphosphates, ATPyS, and AMP-
PNP in 100 mM HEPES-KOH buffer, pH 8. After reactions, sam-
ples were analyzed by TLC and ATP formation was calculated with 
an imaging analyzer. 
respectively, of those of 14-3-3 proteins from a human lym-
phoblastoma. Broad pH optima of 7-9 were observed for 
ATPase and ATP synthesis (data not shown). 
3.3. Nucleotide specificity of NDP kinase-like activity of 14-3-3 
NDP kinase catalyzes the transfer of the y-phosphate group 
from any nucleoside triphosphate to any nucleoside diphos-
phate. As shown in Fig. 3B, NDP kinase used all ribo- and 
deoxyribo-nucleoside triphosphates tested as phosphate do-
nors efficiently, but failed to utilize the non-hydrolyzable 
ATP analogs AMP-PNP and ATPyS. In the presence of an 
equal concentration of ATPyS to ATP, this transfer by NDP 
kinase was competitively inhibited about 52% on incubation 
for 30 min. On the other hand, 14-3-3 preferentially utilized 
ATP, dATP and dGTP, and transferred the y-phosphate 
group to ADP, as shown in Fig. 3A. Of the nucleoside tri-
phosphates, dTTP, dCTP and CTP were poor phosphate do-
nors. Significant inhibition of the activity of 14-3-3 was also 
observed with equal concentrations of ATPyS to ATP. From 
the differences in the reaction times and doses of enzymes 
used in these assays, it is evident that the specific activity 
for ATP synthesis of NDP kinase was approximately 36 times 
that of 14-3-3. 
Next we tested the specificities of nucleotides as acceptors in 
the transfer of the y-32P-phosphate of ATP as catalyzed by 14-
3-3 proteins. As shown in Fig. 4A, 14-3-3 proteins converted 
nucleoside diphosphates (GDP, CDP, UDP, dGDP, dCDP 
and dTDP) to the corresponding nucleoside triphosphates 
with almost similar efficiencies. Similar results were observed 
in the substrate specificity of NDP kinase (Fig. 4B), although 
the conversion efficiency of the NDP kinase was much higher 
than that of 14-3-3. In these assay conditions, the conversions 
of ADP and dADP to ATP and dATP, respectively, were not 
clearly analyzed, because the newly formed products over-
lapped the phosphate donor, [y-32P]ATP. Nevertheless, we 
confirmed that the rates of conversion of [14C]ADP and 
[14C]CDP to the corresponding nucleoside triphosphates by 
14-3-3 proteins were similar (data not shown). 
Since NDP kinase requires Mg2+ or Mn2+ for activity, the 
effects of divalent cations on the ATPase and ATP synthesis 
activities of 14-3-3 were analyzed. Both activities of 14-3-3 
were strongly stimulated by 6 mM Mg2+ and Mn2+ , and 
moderately by Co2+ and Ni2+ (data not shown). 
3.4. Formation of autophosphorylated 14-3-3 intermediates and 
their CDP-dependent dephosphorylation. 
The NDP kinase-like activity of 14-3-3 proteins might be 
due to a contaminant, since the activity is similar to that of 
NDP kinase. However, this possibility is unlikely for the fol-
lowing reasons. First, 14-3-3 proteins purified from a lympho-
blastoma and the recombinant x isoform were >97% and 
>99% pure, respectively, as determined by SDS-PAGE and 
no NDP kinase-like protein bands corresponding to molecular 
masses of about 16 kDa were observed (Fig. 1). Second, no 
immunoreactivity of the samples of 14-3-3 and the recombi-
nant x isoform against anti-NDP kinase-A antibodies was also 
observed as shown in Fig. 1. 
NDP kinase autophosphorylates the active site histidine of 
the intermediate in the process of catalytic phosphate transfer 
reaction [28,29]. 14-3-3 proteins (3 |xg) exhibited autophos-
phorylated intermediate bands corresponding to proteins 
with molecular masses of 32 and 28 kDa (Fig. 5A, lane 1) 
and the recombinant x isoform (1 (ig) gave a 28 kDa auto-
phosphorylated intermediate band (Fig. 5A, lane 3) in the 
absence of nucleoside diphosphate as an acceptor in the re-
action mixture, which contained 10 |xCi of [y-32P]ATP, 100 
uM ATP and 6 mM MgCl2 in HEPES-KOH buffer, pH 8. 
Under the conditions used, no conversion of CDP to CTP by 
14-3-3 proteins and the recombinant T isoform was observed 
(Fig. 5B, lanes 1 and 3, respectively). In the presence of 5 mM 
CDP, however, the radioactivities of these phosphorylated 
intermediates of 14-3-3 and the recombinant 14-3-3 x isoform 
decreased with concomitant formation of 32P-labeled CTP 
from CDP (Fig. 5A, lane 2 and 4, and Fig. 5B, lane 2 and 
4, respectively). Furthermore, decreases in the radioactivities 
of the autophosphorylated intermediates of 14-3-3 proteins 
Fig. 4. Specificity of nucleoside diphosphates as phosphate acceptors for 14-3-3 proteins. The substrate specificities of 14-3-3 proteins (33 pmol) 
(A) and NDP kinase (3.3 pmol) (B) were assayed under the conditions given in Section 2 using 1 uCi of [y-32P]ATP (6000 Ci/mmol) as a phos-
phate donor, 6 mM MgCi2 and 0.5 mM concentrations of various ribo- and deoxyribo-nucleoside diphosphates (lanes 2-9 in A and lanes 1-8 
in B) in 100 mM HEPES-KOH buffer, pH 8, in a total volume of 20 ul. After incubation for 6 h for A and 30 min for B, samples were ana-
lyzed by TLC, followed by autoradiography with an imaging analyzer. 
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Fig. 5. Autophosphorylation and CDP-dependent dephosphorylation 
of 14-3-3 proteins and its 14-3-3 x isoform. Autophosphorylation 
and CDP-dependent dephosphorylation of 14-3-3 proteins (3 ug) 
and its recombinant 14-3-3 x isoform (1 u,g) were analyzed as de-
scribed in Section 2. In the absence of CDP as an acceptor in the 
reaction mixture, 14-3-3 proteins and its recombinant x isoform 
gave two autophosphorylated bands of 28 and 32 kDa and one 
band of 28 kDa on SDS-PAGE, as shown in A, lanes 1 and 3, re-
spectively. Under the conditions used, no conversion of CDP to 
CTP was observed in the analyses by TLC as shown in B, lanes 1 
and 3, respectively. However, in the presence of 5 mM CDP in the 
reaction mixture, decrease in the autophosphorylated intermediates 
of 14-3-3 proteins (A, lane 2) and its recombinant x isoform (A, 
lane 4) with concomitant formation of CTP from CDP (B, lanes 2 
and 4, respectively) was observed. For characterization of alkali 
stability of the autophosphorylated 14-3-3, the phosphorylated x iso-
form in SDS sample buffer at pH 8.5 without boiling was electro-
phoresed, and the gel was dried without acid fixation (A, lane 5) 
[25]. For acid stability, the autophosphorylated protein was boiled 
in SDS sample buffer at pH 6.8, electrophoresed and the gel was 
fixed in 20% trichloroacetic acid, followed by Coomassie staining, 
destaining in methanol/acetic acid, and drying (A, lane 6) [25], 
and the x isoform were also observed on addition of 5 mM 
CDP to the reaction mixture after the first reaction of forma-
tion of autophosphorylated intermediates (data not shown). 
These results indicate that 14-3-3 catalyzes transfer of the y-
phosphate group from ATP to CDP and that this transfer 
involves a phosphoenzyme intermediate. These properties 
are similar to those reported for NDP kinase [28,29]. For 
characterization of the phosphorylation of 14-3-3, the auto-
phosphorylated 14-3-3 T isoform was subjected to acid and 
basic treatments as described [25,29], which allow the evalua-
tion of a high-energy phosphate on basic residues, especially 
on a histidine residue, in NDP kinase and histidine protein 
kinase. The phosphorylated intermediate of the 14-3-3 x iso-
form was stable on basic treatment (Fig. 5A, lane 5), but 
labile on acid treatment, resulting in marked decrease in the 
autophosphorylation level, as shown in Fig. 5A, lane 6. Since 
the phosphorylations of serine, threonine and tyrosine are 
stable on acid treatment, this suggests that the acid-labile 
and alkaline-stable phosphorylated residue(s) in 14-3-3 may 
be a basic amino acid(s), such as histidine, lysine and arginine, 
although this residue(s) has not yet been identified. These 
results strongly indicate that 14-3-3 proteins have similar 
properties to NDP kinase and that the observed activity of 
our preparation was not due to contaminant proteins. 
4. Discussion 
Known functions of 14-3-3 are highly varied, but most of 
them share the features of those of chaperone and adapter 
molecules, mediating protein-protein interactions. Recent 
studies on the crystal structure of the human T-cell 14-3-3 x 
isoform and recombinant C, isoform revealed that each subunit 
of 14-3-3 consists of a bundle of nine antiparallel helices that 
form a palisade around the basic face of an amphipathic 
groove, a putative substrate protein-binding surface [30,31]. 
In the mechanisms of substrate protein binding to, and release 
from a molecular chaperone, such as Hsp70 or DnaK, ATP 
and ADP-dependent cycle of protein/peptide binding and re-
lease has been extensively studied [17-20]. The first step in the 
mechanism involves the binding of a protein/peptide to an 
Hsp70-ADP complex, resulting in a conformational change 
accelerating ADP-ATP exchange in the presence of ATP 
(step 2). The binding of ATP causes a conformational change 
which triggers substrate release from the complex (step 3). 
Finally, ATP is hydrolyzed to ADP to afford an Hsp70-ADP 
complex which then participates in a new cycle of binding 
(step 4). These results suggest that nucleotide exchange is 
rate-limiting in the cycle. The ATPase activity of 14-3-3 pro-
teins was originally reported from studies on their function in 
import of precursor proteins into mitochondria [12-14]. The 
present work established the intrinsic NDP kinase-like activity 
of 14-3-3 proteins, catalyzing not only ATP/ADP exchange 
but also other nucleotide exchanges that may accelerate cycles 
of association and dissociation of substrate proteins with 14-
3-3 and also modulate the functions of substrate proteins. The 
functional significance of the NDP kinase-like activity of 14-3-
3 proteins is unknown, but perhaps it can regulate the asso-
ciation and dissociation of substrate proteins to 14-3-3 and 
also transfer of the y-phosphate group from 14-3-3 to a serine/ 
threonine residue(s) of substrate proteins involving a high-en-
ergy phosphoprotein intermediate, as reported for the 16 kDa 
NDP kinase [32], resulting in modulation of protein binding. 
The precise role of 14-3-3 in cellular regulation awaits further 
biochemical and genetic analyses. 
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